BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 21884747)

  • 1. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.
    Mahmud S; Hammond G; Elliott L; Hilderman T; Kurbis C; Caetano P; Van Caeseele P; Kettner J; Dawood M
    Vaccine; 2011 Oct; 29(45):7975-81. PubMed ID: 21884747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Did the H1N1 Vaccine Reduce the Risk of Admission with Influenza and Pneumonia during the Pandemic?
    Mahmud SM; Bozat-Emre S; Hammond G; Elliott L; Van Caeseele P
    PLoS One; 2015; 10(11):e0142754. PubMed ID: 26600435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal influenza vaccination status among children with laboratory evidence of pandemic H1N1 infection.
    Nelson CA; France EK; Shetterly SM; Glanz JM
    Pediatr Infect Dis J; 2011 Jul; 30(7):562-5. PubMed ID: 21248657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.
    Castilla J; Morán J; Martínez-Artola V; Fernández-Alonso M; Guevara M; Cenoz MG; Reina G; Alvarez N; Arriazu M; Elía F; Salcedo E; Barricarte A;
    Vaccine; 2011 Aug; 29(35):5919-24. PubMed ID: 21723358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
    Gilca V; De Serres G; Hamelin ME; Boivin G; Ouakki M; Boulianne N; Sauvageau C; Dionne M; Gilca R; Skowronski D
    Vaccine; 2011 Dec; 30(1):35-41. PubMed ID: 22063386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
    Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K
    BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea.
    Song JY; Cheong HJ; Heo JY; Noh JY; Choi WS; Park DW; Lee J; Jeong HW; Kee SY; Kim WJ
    Vaccine; 2011 Feb; 29(7):1395-8. PubMed ID: 21199701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009.
    Kelly HA; Grant KA; Fielding JE; Carville KS; Looker CO; Tran T; Jacoby P
    Vaccine; 2011 Aug; 29(37):6419-26. PubMed ID: 21473950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.
    Pebody R; Andrews N; Waight P; Malkani R; McCartney C; Ellis J; Miller E
    Vaccine; 2011 Mar; 29(14):2613-8. PubMed ID: 21292008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children.
    Gilca R; Deceuninck G; De Serres G; Boulianne N; Sauvageau C; Quach C; Boucher FD; Skowronski DM
    Pediatrics; 2011 Nov; 128(5):e1084-91. PubMed ID: 21987710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.
    Bateman AC; Kieke BA; Irving SA; Meece JK; Shay DK; Belongia EA
    J Infect Dis; 2013 Apr; 207(8):1262-9. PubMed ID: 23341536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control study.
    Cheng AC; Kotsimbos T; Kelly HA; Irving LB; Bowler SD; Brown SG; Holmes M; Jenkins CR; Thompson P; Simpson G; Wood-Baker R; Senanayake SN; Brady SJ; Paterson DL; Wark PA; Upham JW; Korman TM; Dwyer DE; Waterer GW; Kelly PM
    Vaccine; 2011 Oct; 29(43):7320-5. PubMed ID: 21810450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study.
    Puig-Barberà J; Arnedo-Pena A; Pardo-Serrano F; Tirado-Balaguer MD; Pérez-Vilar S; Silvestre-Silvestre E; Calvo-Mas C; Safont-Adsuara L; Ruiz-García M;
    Vaccine; 2010 Nov; 28(47):7460-7. PubMed ID: 20875486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(44):1241-5. PubMed ID: 19910912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden.
    Ortqvist A; Berggren I; Insulander M; de Jong B; Svenungsson B
    Clin Infect Dis; 2011 May; 52(10):1203-11. PubMed ID: 21507917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.
    Jiménez-Jorge S; Savulescu C; Pozo F; de Mateo S; Casas I; Ledesma J; Larrauri A; ;
    Vaccine; 2012 May; 30(24):3595-602. PubMed ID: 22472792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.
    Hancock K; Veguilla V; Lu X; Zhong W; Butler EN; Sun H; Liu F; Dong L; DeVos JR; Gargiullo PM; Brammer TL; Cox NJ; Tumpey TM; Katz JM
    N Engl J Med; 2009 Nov; 361(20):1945-52. PubMed ID: 19745214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study.
    Stowe J; Andrews N; Bryan P; Seabroke S; Miller E
    Vaccine; 2011 Nov; 29(51):9467-72. PubMed ID: 22019757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.